Shares of BELLUS Health Inc. (TSE:BLU – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$19.48 and traded as high as C$19.61. BELLUS Health shares last traded at C$19.48, with a volume of 28,666 shares trading hands.
BELLUS Health Trading Down 0.1 %
The company’s 50 day moving average is C$19.48. The company has a market cap of C$2.47 billion, a P/E ratio of -20.29 and a beta of -0.28. The company has a quick ratio of 16.40, a current ratio of 33.42 and a debt-to-equity ratio of 0.32.
About BELLUS Health
BELLUS Health Inc, a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus.
Featured Articles
- Five stocks we like better than BELLUS Health
- Comparing and Trading High PE Ratio Stocks
- United Airlines Soars on Earnings Beat
- Golden Cross Stocks: Pattern, Examples and Charts
- J.B. Hunt Hits the Skids: Lower Prices to Come
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for BELLUS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health and related companies with MarketBeat.com's FREE daily email newsletter.
